Shandong Xinhua Pharmaceutical Company Limited (HKG: 0719)
Hong Kong
· Delayed Price · Currency is HKD 5.24
-0.07 (-1.32%)
Sep 9, 2024, 4:08 PM HKT
Shandong Xinhua Pharmaceutical Company Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 499.47 | 496.51 | 411.06 | 348.55 | 324.86 | 299.97 | Upgrade
|
| Depreciation & Amortization | 524.73 | 514.07 | 489.4 | 438.58 | 385.39 | 344.63 | Upgrade
|
| Other Amortization | 5.72 | 6.18 | 2.75 | 2.48 | 0.41 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -8.7 | -8.73 | -5.54 | -2.07 | -2.49 | -0.84 | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.88 | -33.26 | -39.29 | -84.79 | -72.22 | -34.86 | Upgrade
|
| Loss (Gain) From Sale of Investments | -10.81 | -9.58 | -8.36 | -8.02 | -5.61 | -5.16 | Upgrade
|
| Provision & Write-off of Bad Debts | 6.87 | 10.73 | 5.24 | 2.32 | 0.3 | 0.74 | Upgrade
|
| Other Operating Activities | 64.37 | 107.04 | 122.37 | 97.65 | 144.06 | 159.15 | Upgrade
|
| Change in Accounts Receivable | -670.69 | -423.54 | -717.33 | -751.07 | -683.31 | -301.06 | Upgrade
|
| Change in Inventory | -194.49 | -120.86 | -200.14 | 76.18 | 37.48 | -202.9 | Upgrade
|
| Change in Accounts Payable | 65.83 | -332.39 | 632.33 | 121.63 | 260.2 | 66.93 | Upgrade
|
| Change in Other Net Operating Assets | 42.37 | 53.07 | 45.8 | 3.96 | 8.28 | 8.36 | Upgrade
|
| Operating Cash Flow | 322.55 | 265.28 | 758.24 | 259.12 | 420.19 | 348.27 | Upgrade
|
| Operating Cash Flow Growth | -44.73% | -65.01% | 192.62% | -38.33% | 20.65% | 7.52% | Upgrade
|
| Capital Expenditures | -302.38 | -325.13 | -244.76 | -249.23 | -280.19 | -366.51 | Upgrade
|
| Sale of Property, Plant & Equipment | 10.32 | 11.86 | 7.94 | 2.43 | 3.59 | 2.83 | Upgrade
|
| Investment in Securities | - | - | - | - | -30 | -56.77 | Upgrade
|
| Other Investing Activities | 3.07 | 8.17 | 7.92 | 9.11 | 8.59 | 7.51 | Upgrade
|
| Investing Cash Flow | -288.99 | -305.11 | -228.9 | -237.69 | -298 | -412.94 | Upgrade
|
| Long-Term Debt Issued | - | 862.43 | 833.79 | 551.41 | 1,045 | 1,284 | Upgrade
|
| Long-Term Debt Repaid | - | -888.15 | -1,106 | -603.48 | -902.34 | -1,185 | Upgrade
|
| Net Debt Issued (Repaid) | 66.58 | -25.72 | -272.57 | -52.07 | 142.23 | 98.5 | Upgrade
|
| Issuance of Common Stock | 58.79 | 6.02 | 274.69 | 32.97 | 19 | - | Upgrade
|
| Common Dividends Paid | -171.31 | -175.9 | -163.01 | -148.43 | -126.85 | -116.4 | Upgrade
|
| Other Financing Activities | -8.14 | -0.5 | 30.24 | 27.8 | 0.65 | -28.33 | Upgrade
|
| Financing Cash Flow | -54.08 | -196.11 | -130.66 | -139.73 | 35.04 | -46.23 | Upgrade
|
| Foreign Exchange Rate Adjustments | 17.15 | 6.86 | 15.69 | -7.87 | -12.28 | 1.28 | Upgrade
|
| Net Cash Flow | -3.38 | -229.08 | 414.37 | -126.17 | 144.94 | -109.62 | Upgrade
|
| Free Cash Flow | 20.17 | -59.85 | 513.48 | 9.89 | 140 | -18.24 | Upgrade
|
| Free Cash Flow Growth | -94.01% | - | 5092.02% | -92.94% | - | - | Upgrade
|
| Free Cash Flow Margin | 0.25% | -0.74% | 6.84% | 0.15% | 2.33% | -0.33% | Upgrade
|
| Free Cash Flow Per Share | 0.03 | -0.09 | 0.77 | 0.02 | 0.22 | -0.03 | Upgrade
|
| Cash Income Tax Paid | 145.7 | 239.79 | 66.25 | 44.5 | 118.26 | 187.25 | Upgrade
|
| Levered Free Cash Flow | 367.88 | 50.07 | 779.34 | 222.79 | 496.09 | 135.34 | Upgrade
|
| Unlevered Free Cash Flow | 380.17 | 75.79 | 810.41 | 255.98 | 533.44 | 169.92 | Upgrade
|
| Change in Net Working Capital | 215.95 | 492.5 | -225.48 | 192.11 | -132.82 | 60.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.